INT308205

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.35
First Reported 2009
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 1.25
Pain Relevance 0.08

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular region (PAEP) nucleolus (PAEP) nucleus (PAEP)
PAEP (Homo sapiens)
Pain Link Frequency Relevance Heat
Potency 8 92.84 High High
Inflammation 8 75.16 Quite High
fibrosis 7 38.24 Quite Low
imagery 40 6.88 Low Low
cytokine 3 5.00 Very Low Very Low Very Low
depression 3 5.00 Very Low Very Low Very Low
headache 2 5.00 Very Low Very Low Very Low
anesthesia 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Disease 6 99.24 Very High Very High Very High
Chronic Hepatitis 26 98.38 Very High Very High Very High
Hepatitis B Virus Infection 98 96.00 Very High Very High Very High
INFLAMMATION 6 75.16 Quite High
Hepatitis 17 68.76 Quite High
Infection 16 68.00 Quite High
Recurrence 5 63.60 Quite High
Chronic Hepatitis B 6 52.04 Quite High
Fibrosis 7 38.24 Quite Low
Cirrhosis 10 37.44 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Folding of the PEGs leads to the formation of PEG coils including Gd–DTPA molecules, which are compactly bound to the ether groups of the PEG chains, and the water molecules were loosely bound to the PEG chains [28].
Positive_regulation (leads) of PEG Binding (formation) of
1) Confidence 0.35 Published 2009 Journal Nanoscale Res Lett Section Body Doc Link PMC2894099 Disease Relevance 0 Pain Relevance 0
At 3 years after discontinuation of PEG-IFN ?
Positive_regulation (-) of PEG Binding (discontinuation) of
2) Confidence 0.22 Published 2010 Journal Curr Hepat Rep Section Body Doc Link PMC2945466 Disease Relevance 0.61 Pain Relevance 0
Current guidelines recognize five NA for the treatment of chronic hepatitis B (lamivudine, telbivudine, adefovir, entecavir, and tenofovir), along with two formulations of PEG-IFN (peginterferon ?
Positive_regulation (formulations) of PEG-IFN Binding (peginterferon) of associated with chronic hepatitis
3) Confidence 0.10 Published 2010 Journal Curr Hepat Rep Section Body Doc Link PMC2861769 Disease Relevance 0.64 Pain Relevance 0.08

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox